Preoperative treatment of spasticity with botulinum neurotoxin A to reduce pain in cerebral palsy: is it worthwhile?
Dev Med Child Neurol
.
2019 Sep;61(9):997.
doi: 10.1111/dmcn.14191.
Epub 2019 Feb 14.
Author
Mark Gormley
1
Affiliation
1
Gillette Children's Specialty Healthcare - Physical Medicine, Saint Paul, MN, USA.
PMID:
30761520
DOI:
10.1111/dmcn.14191
No abstract available
Publication types
Comment
MeSH terms
Botulinum Toxins, Type A*
Cerebral Palsy*
Child
Double-Blind Method
Humans
Muscle Spasticity
Neuromuscular Agents*
Pain
Substances
Neuromuscular Agents
Botulinum Toxins, Type A